«Occlusive Dressings

Below is an extended Occlusive Dressings patents listing. Click here to return to the Occlusive Dressings main in depth entry.

Patents :
US Patent No.	Title
7128911	Antigen arrays for treatment of bone disease
7220424	Compositions and methods for enhancing corticosteroid delivery
7220889	Wound dressing
7223899	Wound dressing
7226774	Signal for packaging of influenza virus vectors
7227050	Method for producing a wound dressing
7229624	Ordered molecular presentation of antigens, method of preparation and use
7230029	Fatty acid analogues for the treatment of proliferative skin disorders
7230153	Multilayer conductive appliance having wound healing and analgesic properties
7230154	Wound dressing
7264810	Molecular antigen array
7217422	Compositions and methods for enhancing corticosteroid delivery
7216651	Wound treatment employing reduced pressure
7214847	Multilayer conductive appliance having wound healing and analgesic properties
7132532	Compounds useful in the manufacture of an anti-inflammatory androstane derivative
7138252	Molecular antigen arrays
7144729	Methods and compositions for tissue regeneration
7144845	Compounds useful in the manufacture of an anti-inflammatory androstane derivative
7154017	Method for producing a wound dressing
7176021	Mutant cells with altered sialic acid
7183454	Multipurpose dynamic occlusive dressing
7183455	Adhesive dressing
7198046	Wound treatment employing reduced pressure
7208516	Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione
7276247	Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups
7276529	Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione
7335690	Crosslinkable hydrophilic materials from polymers having pendent Michael donor groups
7342047	Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups
7368456	Methods, compositions, and kits for organ protection during systemic anticancer therapy
7371542	Gene expression system
7378097	Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
7384984	Reactive hydrophilic oligomers
7388074	Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
7396975	Wound dressing and method for manufacturing the same
7402721	Wound dressing
7405206	Anti-inflammatory androstane derivatives
7329645	TGF-.alpha. polypeptides, functional fragments and methods of use therefor
7326535	Immunoreactive peptides from Epstein-Barr virus
7320793	Molecular antigen array
7279165	Amyloid .beta.1-6 antigen arrays
7288265	Treating viral infection at smallpox vaccination site
7288536	Specific glucocorticosteroid compound having anti-inflammatory activity
7291608	Anti-inflammatory 17..beta..-carbothioate ester derivatives of androstane with a cyclic ester group in position 17..alpha.
7291609	Specific glucocorticosteroid compound having anti-inflammatory activity
7291762	Multilayer conductive appliance having wound healing and analgesic properties
7294352	Matrix protein composition for treating inflammation
7304202	Wound dressing
7316817	Method and device for topical delivery of therapeutic agents to the skin
7320783	Methods and compositions for the enhancement of wound healing
7411109	Method for producing a wound dressing

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.